Microban® International Announces a New Range of Antiviral Technologies
plus
Actualités sur Chemie
Zentiva Advances Pharmaceutical Research Through ORBIS Project
Prague (ots/PRNewswire) - One of the missions that Zentiva has consistently pursued is to connect Academia and the Pharmaceutical Industry to accelerate drug development innovation and meet the unmet needs of the patients. Our company is pleased to resume the scientific exchange program as part of the ORBIS project, which was created within the largest EU grant programs HORIZON 2020, to connect European and American ...
plusPanoramix research project set out to evaluate the risk of chemical mixtures for human health
Brussels (ots/PRNewswire) - Panoramix (Providing risk assessments of complex real-life mixtures for the protection of European citizens and the environment), a 4-year project led by the Technical University of Denmark, focuses on innovative ways for quantifying the risk associated with exposure to chemical mixtures, without animal testing. The project is supported by ...
plusEANS-News: Lenzing AG / World-renowned marine research institute confirms biodegradability of LENZING? fibers
issuer: Lenzing AG A-4860 Lenzing phone: +43 7672-701-0 FAX: +43 7672-96301 mail: office@lenzing.com WWW: http://www.lenzing.com ISIN: AT0000644505 indexes: WBI, ATX stockmarkets: Wien language: ...
plusCARB-X FUNDS THE 3RD ROUND OF DEBIOPHARM’S TARGETED ANTIBIOTIC PROGRAM TO COMBAT RESISTANT N. GONORRHOEAE INFECTIONS
Lausanne, Switzerland / Boston, USA (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453, by the Combating Antibiotic-Resistant Bacteria Biopharmaceutical ...
plusSeibersdorf Labor GmbH; Isotopia Molecular Imaging
Isotopia Molecular Imaging and Seibersdorf Labor GmbH Announce Production Agreement for 177Lu n.c.a.
Tel Aviv, Israel and Vienna, Austria (ots/PRNewswire) - Isotopia Molecular Imaging and Seibersdorf Labor are pleased to announce that they have entered into an agreement for the production of no-carrier-added Lutetium-177, a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for ...
plus
Micreos appoints Matt Regan as CEO of its Pharmaceutical business
The Hague, Netherlands (ots/PRNewswire) - Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new Pharmaceutical business that will be based in Switzerland. Following rapid growth, Micreos is preparing to spin-out its Pharmaceutical business into a separate company as per January 2022 to directly access the capital markets. This will help to fund pipeline development to progress its highly ...
plusNovaliq Receives EU Quality Management Certificate According To New Medical Device Regulation (MDR)
Heidelberg, Germany (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced that it has implemented and applies a quality management system in accordance with Annex IX, Chapter I of the EU ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Detecting microplastics in the environment
Bern (ots) - Geochemist Denise Mitrano has found a way to track how micro- and nanoplastic particles spread through the environment. For this work, she is receiving this year's Marie Heim-Vögtlin Prize from the Swiss National Science Foundation. Man-made plastic pollutes the environment. When broken down into micro- and nanoparticles, it poses an increasing problem not only for the oceans and their inhabitants, but also ...
plusEW Nutrition launches Pretect D to support poultry gut health during challenging periods
Visbek (ots) - EW Nutrition announces the launch of a novel gut health solution for poultry. Pretect D, a proprietary blend of phytomolecules, helps maintain bird performance and farm profitability. Trials indicate that Pretect D offers natural support even during Eimeria-related challenges, making it an effective addition to programs focused on gut health issues. ...
plusSasol, Haldor Topsøe expand G2LTM licensing collaboration to grow sustainable synthetic fuels and chemicals globally
Johannesburg (ots/PRNewswire) - Haldor Topsøe and Sasol have expanded collaboration to jointly license and develop their technologies for sustainable liquid fuels and chemicals production through Fischer-Tropsch (FT) technology. Sasol and Topsøe currently offer integrated end-to-end solutions to produce synthetic ...
plusVidac Pharma Ltd.: New Chemical Entities Patent Granted
Rehovot, Israel (ots/PRNewswire) - Vidac Pharma Ltd. announces that it was granted a USA Patent for a new chemical family of compounds targeting the HK2-VDAC system developed by the company. The new compounds are hydrophilic and were developed to fit systemic use such as IV, IM and/or Per-Os use. "This is opening the way to explore possible treatment of solid tumors overexpressing HK2 such as Prostate, Pancreas and other ...
plus
Poda Lifestyle and Wellness Ltd.
Poda Announces Supply Agreement with Biodegradable Filter Manufacturer
Vancouver, Bc (ots/PRNewswire) - PODA LIFESTYLE AND WELLNESS LTD. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTC: PODAF) is pleased to announce that it has entered into a supply agreement (the "Supply Agreement") with biodegradable filter manufacturer Greenbutts, LLC ("Greenbutts"). Greenbutts has developed a natural filter technology that was created to provide ...
plusGES Acquires Aqwise in a Strategic Move to Form a Leading Global Water & Wastewater Treatment Technology Group
Tel Aviv, Israel (ots/PRNewswire) - GES CEO, Michael Dayan, explained that the Aqwise acquisition positions GES as a leading, dominant player in the Water, Industrial & Municipal Wastewater Market in Israel and worldwide GES, which operates in the desalination, water treatment and wastewater sector announced today ...
plusNorgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand
Amsterdam, Netherlands and Louisville, Ky. (ots/PRNewswire) - NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and US WorldMeds (USWM), a Kentucky-based specialty pharmaceutical company, today announced an exclusive licensing agreement by which Norgine will register and commercialise ...
plusServier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics
Paris (ots/PRNewswire) - Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced today that they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological diseases. Under the collaboration ...
plusAlmirall and MC2 Therapeutics announce completion of decentralized procedure in Europe for the topical treatment of mild to moderate psoriasis vulgaris in adults
Barcelona, Spain and Copenhagen, Denmark (ots/PRNewswire) - - The successful completion of a decentralized procedure is the final step before national marketing authorizations can be granted by the European countries - MC2 Therapeutics has granted Almirall exclusive European rights to commercialize this topical ...
plusValcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations
Copenhagen (ots/PRNewswire) - Valcon Medical A/S ("Valcon Medical" or the "Company"), Denmark's leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021. Under the DKMA ...
plus
Norgine B.V. enters into exclusive distribution agreement for the commercialisation of PLENVU® in China with Beijing Podconley Pharmaceutical Technology & Development Co., Ltd.
Amsterdam (ots/PRNewswire) - NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and Beijing Podconley Pharmaceutical Technology & Development Co., Ltd. (Beijing Podconley), today announced an exclusive distribution agreement by which Beijing Podconley will commercialise Norgine's product ...
plusDEBIOPHARM AND UBIX THERAPEUTICS LAUNCH RESEARCH TO DEVELOP A NEW ANTI-CANCER MODALITY - ANTIBODY DEGRADUCER® CONJUGATES
Lausanne, Switzerland, Seoul, Republic of Korea (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech company today announced their co-research agreement combining two novel proprietary technologies to specifically ...
plusDEBIOPHARM’S CD37 ANTIBODY DRUG CONJUGATE SHOWS PROMISING PHASE II RESULTS FOR THE TREATMENT OF B-CELL MALIGNANCIES
Lausanne, Switzerland (ots) - - Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive form of Non-Hodgkin’s Lymphoma (NHL), representing 30-40% of cases. Nearly half of DLBCL patients are not cured by first-line treatment, leaving a large number of patients at risk of worsening disease1 - Naratuximab ...
plusJohnson Matthey: Pgm Prices Soar as Demand Recovers Amid Supply Disruption
London (ots/PRNewswire) - Pgm demand recovered strongly from Covid disruption, with rising auto production, stricter emissions legislation, and resilient industrial demand. Mining and processing outages hit supplies during 2020 and early 2021, driving pgm prices higher. Palladium and rhodium prices surged to new all-time records in early 2021, with both markets in ...
plusEANS-News: ANDRITZ to supply new pickling and galvanizing line and acid regeneration plant with ECOmode to Prosperity Tieh, Taiwan
issuer: Andritz AG Stattegger Straße 18 A-8045 Graz phone: +43 (0)316 6902-0 FAX: +43 (0)316 6902-415 mail: welcome@andritz.com WWW: www.andritz.com ISIN: AT0000730007 indexes: ATX, WBI stockmarkets: Wien language: ...
plusEANS-News: Lenzing AG / Lenzing pushes forward group-wide climate neutrality by investing EUR 200 mn in Asia
issuer: Lenzing AG A-4860 Lenzing phone: +43 7672-701-0 FAX: +43 7672-96301 mail: office@lenzing.com WWW: http://www.lenzing.com ISIN: AT0000644505 indexes: ATX, WBI stockmarkets: Wien language: ...
plus
Firmenich Opens Culinary & SmartProteins® Innovation Hub in Singapore
Geneva (ots/PRNewswire) - Firmenich, the world's largest privately owned fragrance and taste company, today announces the launch of its Culinary and SmartProteins® Innovation Center in Tuas, Singapore. The new center will serve as a regional R&D hub for Asia and a global center of expertise in alternative proteins for meat and dairy analogs. The Innovation Center is ...
plusCAS launches new brand reflecting strategic evolution to empower smarter science
Columbus, Ohio (ots/PRNewswire) - Expanding portfolio of solutions and capabilities addressing growing need for curated scientific data and expertise to accelerate discovery CAS, a division of the American Chemical Society (ACS) that specializes in scientific information solutions, today launched a new brand reflecting the broadening scope of its solutions and ...
plusNew Contract Awarded By Total Corbion PLA To Design A Biopolymer Plant In France
Rome (ots/PRNewswire) - Maire Tecnimont S.p.A. announces that its subsidiary NextChem has been awarded today a contract by Total Corbion PLA, a 50/50 joint venture between Total and Corbion, to carry out a Front-End Engineering Design for their 100,000 tons per annum Poly Lactic Acid (PLA) plant in Grandpuits, France. The plant, due to be operational in 2024, will be ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Novel antibiotic deceives bacteria through mimicry
Bern (ots) - Most antibiotics need to penetrate their target bacteria. But Darobactin, a newly discovered compound, is much too large to do so. Nonetheless, it kills many antibiotic-resistant pathogens - by exploiting a tiny weak spot on their surface. Basel researchers have now revealed the amazing mechanism at play and thereby opened the door to developing completely new medicines. An increasing number of bacterial ...
plusBionical Emas launches Managed Access Program for JZP 458 - a recombinant Crisantaspase produced in Pseudomonas fluorescens
Willington, England (ots/PRNewswire) - Bionical Emas, a global specialist Clinical Research Organization (CRO) has today announced the launch of a Managed Access Program for Jazz Pharmaceuticals' medicinal product JZP-458 for the treatment of patients with Acute Lymphoblastic Leukaemia (ALL) and Lymphoblastic ...
plusAramco and American Concrete Institute announce new Center of Excellence for Nonmetallics in Building and Construction
Farmington Hills, Mich. (ots/PRNewswire) - - Aramco Americas becomes founding member of US-based innovation hub - New center aims to achieve more sustainable building solutions through advances in nonmetallic technologies Aramco and the American Concrete Institute (ACI) announce the launch of NEx: A Center of ...
plus
Précédent1234567Suivant